AWH 0.99 (-33.56%)
US04537Y1091Medical Diagnostics & ResearchDiagnostics & Research

Aspira Womens Health (AWH) Competitor Comparison

We are evaluating the key criteria listed to compare Aspira Womens Health (AWH) against its competitors in the Diagnostics & Research industry.

Performance 10 years - AWH ranking 55 / 58

These are the competitors of Aspira Womens Health in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Medpace Holdings MEDP
1.36K
3. Lantheus Holdings LNTH
1.21K
4. DexCom DXCM
1.05K
5. RadNet RDNT
786.02
6. IDEXX Laboratories IDXX
628.36
7. Icon ICLR
581.46
8. Natera NTRA
501.61
9. Mettler-Toledo MTD
456.92
10. Danaher DHR
368.67
11. Thermo Fisher Scientific TMO
367.85
12. NeoGenomics NEO
325.46
13. IQVIA Holdings IQV
306.46
14. Charles River Laboratories CRL
292.59
15. Twist Bioscience TWST
279.08
16. PerkinElmer PKI
247.07
17. Agilent Technologies A
215.17
18. Waters WAT
176.04
19. Exact Sciences EXAS
153.75
20. Laboratory Corp of America Holdings LH
133.38
21. Quest Diagnostics DGX
132.71
22. Syneos Health SYNH
113.83
23. Fulgent Genetics FLGT
113.03
24. National Research NRC
64.16
25. CareDx CDNA
63.47
26. Qiagen QGEN
63.41
27. Meridian Bioscience VIVO
60.69
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Neogen NEOG
5.07
30. Guardant Health GH
4.07
31. Olink Holding OLK
-28.51
32. Inotiv NOTV
-34.13
33. Myriad Genetics MYGN
-37.28
34. Illumina ILMN
-40.13
35. Sotera Health SHC
-56.04
36. Sera Prognostics SERA
-60.56
37. Bioventus BVS
-61.92
38. Global Cord Blood CO
-66.57
39. DarioHealth DRIO
-68.27
40. Anixa Biosciences ANIX
-70.53
41. bioAffinity Technologies BIAF
-74.29
42. MaxCyte MXCT
-76.93
43. Pacific Biosciences of California PACB
-77.39
44. Enzo Biochem ENZ
-77.8
45. Co-Diagnostics CODX
-79.17
46. MDxHealth MDXH
-80.33
47. Psychemedics PMD
-83.02
48. Biodesix BDSX
-88.74
49. Exagen XGN
-89.17
50. Trinity Biotech TRIB
-90.85
51. Neuronetics STIM
-92.8
52. Personalis PSNL
-95.04
53. Prenetics Global PRE
-95.05
54. SeqLL SQL
-95.1
55. Aspira Womens Health AWH
-96.04
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.74
58. Precipio PRPO
-99.8

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.